Cellceutix CEO Lion Ehrlich Interviewed by TheStreetBeat.com MarketWatch (press release) In the interview, Mr. Paul Ehrlich speaks with The Street Beat reporter Bolton Flautt about ongoing activities At Cellceutix with the iii of its drugs that are actively being formed as indications for cancer, psoriasis and autism. and more » Link To Article
No comments:
Post a Comment